Xinhua Healthcare Signs an Exclusive License Agreement with ArcDia for its mariPOC Technology in China

 Xinhua Healthcare Signs an Exclusive License Agreement with ArcDia for its mariPOC Technology in China

Xinhua Healthcare Signs an Exclusive License Agreement with ArcDia for its mariPOC Technology in China

Shots:

  • Xinhua Healthcare to get exclusive license rights to commercialize ArcDia’s mariPOC platform in China. ArcDia to supply biochemical assay components and R&D services to Xinhua
  • The focus of the collaboration is to expand Xinhua’s IVD business in point-of-care testing (POCT) and localize ArcDia’s mariPOC technology in addition to building up of a production capacity for decentralized infection diagnostic services in China
  • ArcDia’s mariPOC IVD platform is an automated POC test system designed for the rapid multianalyte identification and detection of pathogens & inflammation markers focusses on respiratory tract infections, tonsillitis and gastroenteritis 

Click here to read full press release/ article | Ref: ArcDia | Image: Twitter

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post